A
Allegheny Health Network | Allegheny Endocrinology Associates
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Octreotide
Relamorelin
Bococizumab
Pasireotide
Paltusotine
LY3437943
Somatostatin
SOM230
Parent organization
This site is a part of Allegheny Health Network
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 18 total trials
The purpose of this trial is to assess the long-term safety and efficacy of CAM2029 in patients with acromegaly. Patients will be administered CAM202...
Active, not recruiting
Acromegaly
Drug: CAM2029 (octreotide subcutaneous depot)
Trial sponsors
C
C
C
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems